Status:
TERMINATED
Suture-based, Minimally Invasive Technique Used to Correct NSD
Lead Sponsor:
Stanford University
Conditions:
Nasal Septum; Deviation, Congenital
Nasal Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nasal Septal Deviation (NSD) is one of the most common indications for surgery seen by ENT physicians, however, correction requires open surgery which is associated with several weeks of recovery. The...
Detailed Description
Nasal obstruction due to structural issues such as nasal septal deviation (NSD) is remarkably common. NSD is caused by warping of the midline cartilage and bone of the septum, which starts between the...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Patients from all ethnic and geographic backgrounds within the Stanford Sinus Center with symptomatic NSD
- Primary patients with NSD without past septum surgery
- Patients who have failed maximum medical therapy
- Patients whose symptoms, examination and/or imaging findings are sufficiently severe as to warrant septoplasty as determined by the treating surgeon
Exclusion
- Age \< 18
- Recent surgery of any kind (\<1 month)
- Inpatients
- Previous nasal septum surgery
Key Trial Info
Start Date :
August 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04891263
Start Date
August 2 2021
End Date
September 13 2021
Last Update
April 3 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Ambulatory Surgery Center, Stanford Hospital
Palo Alto, California, United States, 94304
2
Stanford Sinus Center/ Adult Comprehensive ENT Clinic
Stanford, California, United States, 94305